Eli Lilly | Despesas De Vendas E Administração



Selling And Administration Expenses Alterar Data
AbbVie USD 3.25B 40M 2025-06
Abbott USD 3.09B 39M 2025-06
ALKERMES USD 153.87M 17.83M 2025-06
Amgen USD 1.69B 191M 2025-03
AstraZeneca USD 5.01B 1.42B 2025-06
Baxter International USD 718M 15M 2025-06
Biogen USD 583.8M 11.3M 2025-06
Bristol-Myers Squibb USD 1.71B 129M 2025-06
Drreddys Laboratories INR 21.59B 436M 2024-12
Eli Lilly USD 2.75B 390.8M 2025-06
Gilead Sciences USD 1.36B 100M 2025-06
GlaxoSmithKline GBP 2.14B 80M 2025-06
Glaxosmithkline GBP 2.7B 632M 2024-12
J&J USD 5.89B 777M 2025-06
Medtronic USD 2.7B 17M 2025-04
Merck USD 2.63B 104M 2025-06
Neurocrine Biosciences USD 286.3M 9.8M 2025-06
Novartis USD 3.44B 384M 2025-06
Novartis USD 3.5B 368M 2024-12
Novo Nordisk 18.85B 2.74B 2025-06
Perrigo USD 273.1M 8.1M 2025-06
Pfizer USD 3.42B 406M 2025-06
Prestige Brands USD 28.46M 35.6M 2025-06
Regeneron Pharmaceuticals USD 634.2M 1.2M 2025-06
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 2.63B 408M 2025-06
Sanofi EUR 1.24B 1.44B 2024-12
United Therapeutics USD 212.5M 42.4M 2025-06
Zoetis USD 617M 54M 2025-06


Eli Lilly Despesas De Vendas E Administração - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.